Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?

Pataky, Zoltan; Carrard, Isabelle; Gay, Valérie; Thomas, Aurélien; Carpentier, Anne; Harsch-Bobbioni, Elisabetta; Golay, Alain

doi:10.1159/000487890

Scientific article

English

Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?

ContributorsPataky, Zoltan

; Carrard, Isabelle; Gay, Valérie; Thomas, Aurélien; Carpentier, Anne; Harsch-Bobbioni, Elisabetta; Golay, Alain

Published inObesity Facts, vol. 11, no. 2, p. 144-156

Publication date2018

Abstract

To evaluate the effects of weight loss on endocannabinoids, cardiometabolic and psychological parameters, eating disorders (ED) as well as quality of life (QoL) and to elucidae the role of endocannabinoids in metabolic syndrome (MS).

Keywords

Weight loss
Metabolic syndrome
Endocannabinoids
Eating disorders
Quality of life
Patient education

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires

Research groups

Education thérapeutique du patient, diabète et obésité (600)

Citation (ISO format)

PATAKY, Zoltan et al. Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids? In: Obesity Facts, 2018, vol. 11, n° 2, p. 144–156. doi: 10.1159/000487890

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:115535
DOI : 10.1159/000487890
PMID : 29631275

Commercial URLhttps://www.karger.com/Article/FullText/487890

Journal ISSN1662-4025

405views

0downloads

Creation12/11/2018 16:36:00

First validation12/11/2018 16:36:00

Update time15/03/2023 17:04:14

Status update15/03/2023 17:04:14

Last indexation31/10/2024 14:04:51

Archive ouverte UNIGE

Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?

To evaluate the effects of weight loss on endocannabinoids, cardiometabolic and psychological parameters, eating disorders (ED) as well as quality of life (QoL) and to elucidae the role of endocannabinoids in metabolic syndrome (MS).

Technical informations